GWM
TMDX icon

Gilpin Wealth Management’s Transmedics TMDX Stock Holding History

Gilpin Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$597 Buy
6
+4
+200% +$522 ﹤0.01% 565
2025
Q4 		$244 Buy
+2
New +$251 ﹤0.01% 608

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gilpin Wealth Management's TMDX Position: Q1 2026 in Review

Gilpin Wealth Management increased its Transmedics (TMDX) stake by 200% in Q1 2026, buying an estimated $522 and bringing the position to 6 shares worth $597. The position accounts for ﹤0.01% of the portfolio, ranked #565.

Gilpin Wealth Management first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Gilpin Wealth Management held 6 shares of Transmedics worth $597 as of Q1 2026.
  • Gilpin Wealth Management bought 4 Transmedics shares in Q1 2026, an estimated $522.
  • Transmedics made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q1 2026, its #565 holding.
  • Gilpin Wealth Management first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Gilpin Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.